QiMing Venture Partners

QiMing Venture Partners

Qiming Venture Partners is a venture capital firm in China that focuses on building new companies in the country.

Qiming Venture Partners is a venture capital firm in China that focuses on building new companies in the country. Founded 2006 in Shanghai, China, it invests in early stage ventures, late stage ventures, post-IPO, private equity, series C, series B, series D, and series A. Its portfolio companies include Nice Tuan, Cadent Therapeutics, Yunyinggu, Nuohui Health, Abbisko Therapeutics, ShouTi, Singular Medical, NVX Clouds Tech, and Fingo. As of June 2020, Qiming Venture Partners has made 571 investments. Their most recent investment was on May 30, 2020, when Nice Tuan raised $81.4M. Qiming Venture Partners has made 571 investments. Their most recent investment was on May 30, 2020, when Nice Tuan raised $81.4M.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
ByteDance

ByteDance is a Beijing-based company founded in 2012 by Zhang Yiming.

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

CanSino Biologics (CanSinoBIO) is a bio pharmaceutical company primarily producing vaccines.

A computer software company with a graph analytics platform. It was founded in 2012 and is located in Redwood City, California.

Face++ is a company developing and operating a face detection, recognition, and analysis platform for websites, mobile applications and smart televisions.

U.S-based web platform connecting insurance providers and payers.

A biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.

Amoy Diagnostics is a company that develops molecular diagnostics for oncology precision medicine

Unisound, or Beijing Yunzhisheng Information Technology, is a company developing intelligent voice and speech processing technologies.

Xiaomi is an electronics company that manufactures and distributes mobile phones and other electronics.

CooTek is a Shanghai-based mobile application development company.

ITutorGroup provides an online educational platform for students and business professionals.

UBTech Robotics is a company designing, manufacturing and commercializing humanoid robots.

CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.

Hesai Technology develops smart sensing technology solutions and manufactures laser sensors for LiDARs.

Tuhu is a company providing an automobile after-sales products and services via its website, mobile application, call center and third-party e-commerce platforms.

RedDoorz is a platform offering budget accommodations across key business and tourist destinations in Southeast Asia.

Micropoint Bioscience is a Santa Clara, California-based diagnostic tools company developing immunoassay systems and solutions.

Pratilipi is an India-based digital media company.

CastBox is a San Francisco-based company.

Kezar Life Sciences is a South San Francisco, California-based company.

37 Results
Results per page:
Page 1 of 2

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
Qiming Venture Partners VI, L.P.
900,000,000
March 20, 2018
1,100,000,000
April 2020
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Duane Kuang

Founding Managing Partner

Gary Rieschel

Founding Managing Partner

Nisa Leung

Managing Partner

William Hu

Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Abbisko Therapeutics

Cadent Therapeutics

Nice Tuan

Nuohui Health

Yunyinggu

News

Title
Author
Date
Publisher
Description
Qiming Venture Partners
February 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Qiming's portfolio company New Horizon Health (SEHK:6606) officially listed on the Main Board of Hong Kong Stock Exchange (HKEx) today. This is...
Qiming Venture Partners
January 26, 2021
www.prnewswire.com:443
/PRNewswire/ -- Qiming Venture Partners ("Qiming") today announced the final close of our RMB Fund VI at RMB 2.852 billion. Currently, Qiming has $5.9 billion...
Qiming Venture Partners
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board...
Eudora Wang
December 17, 2020
DealStreetAsia
dMed is expanding its investor base to prepare for a future IPO.
Qiming Venture Partners
November 20, 2020
www.prnewswire.com:443
/PRNewswire/ -- Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.